Skip to main content
Journal of the Egyptian National Cancer Institute

Table 4 Relationship among the top 20 selected genes based on regression models and different types of cancer

From: Using the Precision Lasso for gene selection in diffuse large B cell lymphoma cancer

Method

miRNA

Disease

Target (DLBCL)

Reference

Ridge

hsa-let-7i-3p

hepatocellular carcinoma (HCC)

 

[13]

hsa-miR-361-3p

non-small cell lung cancer (NSCLC)

 

[14]

hsa-miR-421

diffuse large B-cell lymphoma (DLBCL)

*

[15]

hsa-miR-136-5p

carcinoma

 

[16]

hsa-miR-223-5p

diffuse large B-cell lymphoma (DLBCL)

*

[17]

hsa-miR-29a-5p

diffuse large B-cell lymphoma (DLBCL)

*

[18]

hsa-miR-331-3p

diffuse large B-cell lymphoma (DLBCL)

*

[19]

hsa-miR-425-3p

renal cell carcinoma (RCC)

 

[20]

hsa-miR-296-5p

diffuse large B-cell lymphoma (DLBCL)

*

[21]

hsa-miR-376a-3p

hepatocellular carcinoma (HCC)

 

[22]

hsa-miR-335-5p

gastric cancer

 

[23]

hsa-miR-584-5p

renal cell carcinoma (RCC)

 

[24]

hsa-miR-500a-5p

breast cancer

 

[25]

hsa-miR-33a-5p

lung cancer

 

[26]

hsa-miR-18a-3p

diffuse large B-cell lymphoma (DLBCL)

*

[27]

hsa-miR-328

diffuse large B-cell lymphoma (DLBCL)

*

[28]

hsa-miR-154-5p

carcinoma

 

[29]

hsa-miR-30d-5p

non-small cell lung cancer (NSCLC)

 

[30]

hsa-miR-326

 non-small cell lung cancer (NSCLC)

 

[31]

hsa-miR-30e-3p

non-small cell lung cancer (NSCLC)

 

[32]

Lasso

hsa-miR-223-5p

diffuse large B-cell lymphoma (DLBCL)

*

[17]

hsa-miR-197-3p

diffuse large B-cell lymphoma (DLBCL)

*

[33]

hsa-miR-652-3p

non-small cell lung cancer (NSCLC)

 

[34]

hsa-miR-27a-3p

diffuse large B-cell lymphoma (DLBCL)

*

[17]

hsa-miR-342-3p

non-small cell lung cancer (NSCLC)

 

[35]

Elastic Net

hsa-miR-223-5p

diffuse large B-cell lymphoma (DLBCL)

*

[17]

hsa-miR-197-3p

diffuse large B-cell lymphoma (DLBCL)

*

[33]

hsa-miR-27a-3p

diffuse large B-cell lymphoma (DLBCL)

*

[17]

hsa-miR-326

non-small cell lung cancer (NSCLC)

 

[31]

hsa-miR-148a-3p

gastric cancer

 

[36]

hsa-miR-652-3p

non-small cell lung cancer (NSCLC)

 

[34]

hsa-miR-342-3p

non-small cell lung cancer (NSCLC)

 

[35]

Precision Lasso

hsa-miR-190a

diffuse large B-cell lymphoma (DLBCL)

*

[37]

hsa-miR-208a

Non-small cell lung cancer (NSCLC)

 

[38]

hsa-miR-10a-5p

renal cell carcinoma

 

[39]

hsa-miR-182-5p

hepatocellular carcinoma (HCC)

 

[40]

hsa-let-7i-3p

hepatocellular carcinoma (HCC)

 

[13]

hsa-miR-20a-3p

diffuse large B-cell lymphoma (DLBCL)

*

[41]

hsa-miR-1

   

hsa-miR-92b-3p

esophageal squamous cell carcinoma (ESCC)

 

[42]

hsa-miR-29a-5p

diffuse large B-cell lymphoma (DLBCL)

*

[18]

hsa-miR-361-3p

non-small cell lung cancer (NSCLC)

 

[14]

hsa-miR-18a-3p

diffuse large B-cell lymphoma (DLBCL)

*

[27]

hsa-miR-223-5p

diffuse large B-cell lymphoma (DLBCL)

*

[17]

hsa-miR-95

Carcinoma

 

[43]

hsa-miR-200a-3p

diffuse large B-cell lymphoma (DLBCL)

*

[44]

hsa-miR-154-5p

Carcinoma

 

[29]

hsa-miR-328

diffuse large B-cell lymphoma (DLBCL)

*

[28]

hsa-miR-326

non-small cell lung cancer (NSCLC)

 

[31]

hsa-miR-421

diffuse large B-cell lymphoma (DLBCL)

*

[15]

hsa-miR-425-3p

renal cell carcinoma (RCC)

 

[20]

hsa-miR-331-3p

diffuse large B-cell lymphoma (DLBCL)

*

[19]

Back to article page